SEC Company Response from Akso Health Group (AHG) (CIK 0001702318) (AHG) — Oct 24, 2017
Akso Health Group (AHG) (CIK 0001702318)
Date: Oct. 24, 2017 · CIK: 0001702318 · Accession: 0001104659-17-063424
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-38245, 333-220720
Letter
VIA EDGAR CORRESPONDENCE Division of Corporation Finance Washington, D.C. 20549-7561 Re: Hexindai Inc. (CIK No. 0001702318) Registration Statement on Form 8-A (Registration No. 001-38245)
Dear Ladies and Gentlemen:
Reference is made to the request to accelerate the effectiveness of the Registration Statement on Form F-1 (Registration No. 333-220720) and the Registration Statement on Form 8-A (Registration Statement No. 001-38245) submitted by Hexindai Inc. (the “Company”) to the Securities and Exchange Commission (the “Commission”) on October 20, 2017.
The Company has applied to list its American depositary shares representing its ordinary shares on the NASDAQ Global Market under the symbol “HX.” The Company hereby clarifies with the Commission that it requests that the Registration Statement on Form 8-A under the Securities Exchange Act of 1934, covering the American depositary shares representing ordinary shares of the Company, be declared effective upon the later of the receipt by the Commission of the certification from the NASDAQ Global Market LLC or effectiveness of the Registration Statement on Form F-1 (Registration No. 333-220720).
Sincerely yours,
/s/ Zhou Xinming
Show Raw Text
CORRESP 1 filename1.htm October 23, 2017 VIA EDGAR CORRESPONDENCE Erin E. Martin, Special Counsel David Lin, Staff Attorney Michael Henderson, Staff Accountant Robert Klein, Staff Accountant Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Re: Hexindai Inc. (CIK No. 0001702318) Registration Statement on Form 8-A (Registration No. 001-38245) Dear Ladies and Gentlemen: Reference is made to the request to accelerate the effectiveness of the Registration Statement on Form F-1 (Registration No. 333-220720) and the Registration Statement on Form 8-A (Registration Statement No. 001-38245) submitted by Hexindai Inc. (the “Company”) to the Securities and Exchange Commission (the “Commission”) on October 20, 2017. The Company has applied to list its American depositary shares representing its ordinary shares on the NASDAQ Global Market under the symbol “HX.” The Company hereby clarifies with the Commission that it requests that the Registration Statement on Form 8-A under the Securities Exchange Act of 1934, covering the American depositary shares representing ordinary shares of the Company, be declared effective upon the later of the receipt by the Commission of the certification from the NASDAQ Global Market LLC or effectiveness of the Registration Statement on Form F-1 (Registration No. 333-220720). Sincerely yours, /s/ Zhou Xinming Name: Zhou Xinming Title: Chief Executive Officer and Director Enclosures CC: Stephanie Tang, Partner, Shearman & Sterling